Back

Mitochondrial OPA1 deficiency causes reversible defects in adult neurogenesis-associated spatial memory in mice

Andraini, T.; Mouledous, L.; Petsophonsakul, P.; Florian, C.; Lopez, S.; Daloyau-Botella, M.; Arrazola, M.; Nikolla, K.; Philip, A.; Leydier, A.; Marque, M.; Arnaune-Pelloquin, L.; Belenguer, P.; Rampon, C.; Miquel, M.-C.

2021-11-19 neuroscience
10.1101/2021.11.16.468792 bioRxiv
Show abstract

Mitochondria are integrative hubs central to cellular adaptive pathways. Such pathways are critical in highly differentiated post-mitotic neurons, the plasticity of which sustains brain function. Consequently, defects in mitochondrial dynamics and quality control appear instrumental in neurodegenerative diseases and may also participate in cognitive impairments. To directly test this hypothesis, we analyzed cognitive performances in a mouse mitochondria-based disease model, due to haploinsufficiency in the mitochondrial optic-atrophy-type-1 (OPA1) protein. While in Dominant Optic Atrophy (DOA) models, the known main symptoms are late onset visual deficits, we discovered early impairments in hippocampus-dependent spatial memory attributable to defects in adult neurogenesis. Moreover, less connected hippocampal adult-born neurons showed a decrease in mitochondrial content. Remarkably, modulating mitochondrial function through voluntary exercise or pharmacological treatment restored spatial memory. Altogether, our study identifies a crucial role for OPA1-dependent mitochondrial functions in adult neurogenesis, and thus in hippocampal-dependent cognitive functions. More generally, our findings show that adult neurogenesis is highly sensitive to mild mitochondrial defects, generating impairments in spatial memory that can be detected at an early stage and counterbalanced by physical exercise and pharmacological targeting of mitochondrial dynamics. Thus, early amplification of mitochondrial function appears beneficial for late-onset neurodegenerative diseases.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Cell Death & Disease
126 papers in training set
Top 0.1%
18.2%
2
Nature Communications
4913 papers in training set
Top 10%
14.4%
3
EMBO Molecular Medicine
85 papers in training set
Top 0.1%
8.2%
4
Aging Cell
144 papers in training set
Top 0.9%
6.7%
5
Brain
154 papers in training set
Top 1%
6.2%
50% of probability mass above
6
EMBO reports
136 papers in training set
Top 0.4%
4.8%
7
eLife
5422 papers in training set
Top 27%
3.5%
8
Cell Reports
1338 papers in training set
Top 16%
3.5%
9
Molecular Psychiatry
242 papers in training set
Top 1%
2.4%
10
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 28%
2.0%
11
PLOS Biology
408 papers in training set
Top 8%
1.8%
12
Advanced Science
249 papers in training set
Top 10%
1.8%
13
iScience
1063 papers in training set
Top 16%
1.7%
14
Developmental Cell
168 papers in training set
Top 9%
1.6%
15
Acta Neuropathologica
51 papers in training set
Top 0.8%
1.3%
16
Neurobiology of Disease
134 papers in training set
Top 3%
1.3%
17
Science Advances
1098 papers in training set
Top 23%
1.2%
18
Progress in Neurobiology
41 papers in training set
Top 1%
1.2%
19
EMBO Reports
88 papers in training set
Top 0.4%
0.9%
20
The EMBO Journal
267 papers in training set
Top 4%
0.9%
21
Cell Death & Differentiation
48 papers in training set
Top 0.6%
0.9%
22
Nature Metabolism
56 papers in training set
Top 2%
0.8%
23
Cells
232 papers in training set
Top 7%
0.7%
24
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.7%
25
Current Biology
596 papers in training set
Top 16%
0.6%